AdaptHealth Q4 2023 Earnings Report

AdaptHealth EPS Results

• Actual EPS: $0.64
• Consensus EPS: $0.20
• Beat/Miss: Beat by +$0.44
• One Year Ago EPS: N/A

AdaptHealth Revenue Results

• Actual Revenue: $858.23 million
• Expected Revenue: $825.94 million
• Beat/Miss: Beat by +$32.29 million
• YoY Revenue Growth: N/A

AdaptHealth Announcement Details

• Quarter: Q4 2023
• Date: 2/27/2024
• Time: N/A

AdaptHealth (NASDAQ:AHCO), together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.